DANIEL MCLEAN: Open Payments
NPI 1083955090 · RIDGEFIELD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 74 payments from 22 companies in 2025. Trend: 2023 $812 · 2024 $1,329 · 2025 $1,905
Food & beverage: $1,905
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $426 |
| PFIZER INC. | 13 | $234 |
| Lilly USA, LLC | 7 | $226 |
| GlaxoSmithKline, LLC. | 8 | $164 |
| Madrigal Pharmaceuticals | 1 | $109 |
| Novo Nordisk Inc | 4 | $102 |
| Amgen Inc. | 4 | $94 |
| Exact Sciences Corporation | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Corcept Therapeutics | 2 | $57 |
Products named: AIRSUPRA, ELIQUIS, ZEPBOUND, REZDIFFRA, EVENITY, TRELEGY ELLIPTA, MOUNJARO, PAXLOVID.
Industry payments across WA — which companies pay providers there.
